心力衰竭患者的蛋白质丰富冰淋的经验和营养相关性 - 一项试点研究
Rebecca Gagnemo Persson1, Eva Drevenhorn1, Helena Rosén1
1Dept of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Heliyon
|July 23, 2024
概括
患有心力衰竭的患者发现蛋白质丰富的冰淋具有吸引力和美味,有助于营养摄入. 需要进一步的研究,以充分评估其营养相关性,以改善营养不良患者的状况.
科学领域:
- 心脏病学 心脏病学
- 营养科学 营养科学
- 饮食干预 饮食干预
背景情况:
- 患有心力衰竭 (HF) 的患者有营养不良的风险增加.
- 提高营养摄入量对于管理HF患者至关重要.
- 营养不良可能会加剧HF症状和预后.
研究的目的:
- 为了探索心脏重症监护室心力衰竭患者食用蛋白质丰富的冰淋的经验.
- 为了评估这种冰淋作为中餐补充剂的营养相关性.
- 为了收集患者对口感,一致性和味道的反.
主要方法:
- 一项采用定性和定量方法的试点研究.
- 使用诱导性内容分析分析的半结构面试.
- 使用描述性统计数据分析日记集.
主要成果:
- 富含蛋白质的冰淋被患者认为是有吸引力和美味的,尽管他们的疾病.
- 患者与一致性的经验因个体状况而异.
- 患者消耗了大量的冰淋,从500毫升到2550毫升.
- 参与者提供了额外风味的建议.
结论:
- 患者的经验提供了有价值的见解,可以改善两餐间的零食,以提高食欲不佳的患者的营养状况.
- 目前的方法需要进一步开发,以最终评估蛋白质丰富冰淋在这个群体中的营养相关性.
- 这项研究强调了可口补充剂在治疗心脏病患者营养不良方面的潜力.
相关概念视频
Proteins: Dietary Sources and Requirements
423
Consuming animal-based products offers high-quality proteins that contain optimal levels and combinations of essential amino acids, crucial for tissue repair and growth. Foods like eggs, milk, fish, and most meats are a source of complete proteins. Legumes and cereals are abundant in proteins; however, they typically lack a full range of essential amino acids. As a result, they are considered incomplete protein sources. Some plant sources like soybeans, quinoa, and amaranth do contain complete...
423
Exercise and Cardiovascular Response
769
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
769
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
Heart Failure Drugs: Diuretics
356
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
356
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inotropic Agents
559
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
559


